Topical ruxolitinib actually has an FDA submission in for vitiligo so there will probably be a defined pathway to approval now. They treated 300 people so a long way to go until CUV recruits that big a trial.
Topical ruxolitinib actually has an FDA submission in for...
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.86 |
Change
-0.200(1.33%) |
Mkt cap ! $744.5M | |||
| Open | High | Low | Value | Volume |
| $15.07 | $15.10 | $14.83 | $1.079M | 72.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1876 | $14.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.99 | 219 | 1 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$14.89 |
Change
-0.200 ( 1.34 %) |
||||
| Open | High | Low | Volume | ||
| $15.08 | $15.09 | $14.84 | 7333 | ||
| Last updated 15.59pm 02/05/2024 ? | |||||
| CUV (ASX) Chart |